Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Topics in Stroke Rehabilitation
|
September 13, 2018
Moderate-to-vigorous physical activity and the risk of stroke recurrence in patients with a history of minor ischemic stroke in Japan: a retrospective analysis
Miyuki Ushio, Maki Kanaoka, Yumiko Kinoshita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 23, 2017
[Geriatric Oncology]
Satoko Maeno, Fumio Nagashima, Daisuke Naruge, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 25, 2018
[The Risk Factors of Cancer Chemotherapy in Elderly Patients]
Eriko Nozaki, Satoko Maeno, Fumio Nagashima, et al.
Japan Journal of Nursing Science : JJNS
|
August 5, 2021
The effect of real-time monitoring of physical activity intensity in diabetic patients
Rumi Tanaka, Kimie Fujita, Satoko Maeno, et al.
The Oncologist
|
October 3, 2020
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study)
Naohiro Okano, Junji Furuse, Makoto Ueno, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Topics in Stroke Rehabilitation
|
September 13, 2018
Moderate-to-vigorous physical activity and the risk of stroke recurrence in patients with a history of minor ischemic stroke in Japan: a retrospective analysis
Miyuki Ushio, Maki Kanaoka, Yumiko Kinoshita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 23, 2017
[Geriatric Oncology]
Satoko Maeno, Fumio Nagashima, Daisuke Naruge, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 25, 2018
[The Risk Factors of Cancer Chemotherapy in Elderly Patients]
Eriko Nozaki, Satoko Maeno, Fumio Nagashima, et al.
Japan Journal of Nursing Science : JJNS
|
August 5, 2021
The effect of real-time monitoring of physical activity intensity in diabetic patients
Rumi Tanaka, Kimie Fujita, Satoko Maeno, et al.
The Oncologist
|
October 3, 2020
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study)
Naohiro Okano, Junji Furuse, Makoto Ueno, et al.
Page
of 1